{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:40:02Z","timestamp":1772815202904,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T00:00:00Z","timestamp":1261699200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00404-009-1330-7","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T07:22:04Z","timestamp":1261639324000},"page":"417-425","source":"Crossref","is-referenced-by-count":13,"title":["Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience"],"prefix":"10.1007","volume":"282","author":[{"given":"Ahmet","family":"Bilici","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taflan","family":"Salepci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faysal","family":"Dane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Gumus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bala Basak Oven","family":"Ustaalioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Seker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik","family":"Salman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Turan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"Unal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Yaylaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,25]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","volume":"57","author":"A Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43\u201366","journal-title":"CA Cancer J Clin"},{"key":"1330_CR2","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519\u20132529","journal-title":"N Engl J Med"},{"key":"1330_CR3","first-page":"1364","volume-title":"Cancer: principles and practice of oncology","author":"BY Karlan","year":"2005","unstructured":"Karlan BY, Markman MA, Eifel PJ (2005) Ovarian cancer, peritoneal carcinoma and fallopian tube carcinoma. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn edn. Williams and Wilkins, Lippincott, pp 1364\u20131397","edition":"7"},{"key":"1330_CR4","first-page":"308","volume":"5","author":"BB Yeole","year":"2004","unstructured":"Yeole BB, Kumar AV, Kurkure A, Sunny L (2004) Population-based survival from cancers of breast, cervix and ovary in women in Mumbai, India. Asian Pac J Cancer Prev 5:308\u2013315","journal-title":"Asian Pac J Cancer Prev"},{"key":"1330_CR5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1098-2388(200007\/08)19:1<3::AID-SSU2>3.0.CO;2-S","volume":"19","author":"CH Holschneider","year":"2000","unstructured":"Holschneider CH, Berek JS (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol 19:3\u201310","journal-title":"Semin Surg Oncol"},{"key":"1330_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1047-2797(99)00045-9","volume":"10","author":"CM Beard","year":"2000","unstructured":"Beard CM, Hartmann LC, Atkinson EJ, O\u2019Brien PC, Malkasian GD, Keeney GL, Melton LJ III (2000) The epidemiology of ovarian cancer: a population-based study in Olmsted County, Minnesota, 1935\u20131991. Ann Epidemiol 10:14\u201323","journal-title":"Ann Epidemiol"},{"key":"1330_CR7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","volume":"170","author":"WJ Hoskins","year":"1994","unstructured":"Hoskins WJ, McGuire WP, Brady MF, Homesley HD, Creasman WT, Berman M, Ball H, Berek JS (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170:974\u2013979","journal-title":"Am J Obstet Gynecol"},{"key":"1330_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","volume":"47","author":"WJ Hoskins","year":"1992","unstructured":"Hoskins WJ, Bundy BN, Thigpen JT, Omura GA (1992) The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 47:159\u2013166","journal-title":"Gynecol Oncol"},{"key":"1330_CR9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"1330_CR10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ygyno.2008.09.041","volume":"112","author":"S Tangjitgamol","year":"2009","unstructured":"Tangjitgamol S, Manusirivithaya S, Laopaiboon M, Lumbiganon P (2009) Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review. Gynecol Oncol 112:257\u2013264","journal-title":"Gynecol Oncol"},{"key":"1330_CR11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO;2-U","volume":"91","author":"Y Ansquer","year":"2001","unstructured":"Ansquer Y, Leblanc E, Clough K, Morice P, Dauplat J, Mathevet P, Lhomm\u00e9 C, Scherer C, Tigaud JD, Benchaib M, Fourme E, Castaigne D, Querleu D, Dargent D (2001) Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study. Cancer 91:2329\u20132334","journal-title":"Cancer"},{"key":"1330_CR12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11864-001-0053-1","volume":"2","author":"ME Burg van der","year":"2001","unstructured":"van der Burg ME (2001) Advanced ovarian cancer. Curr Treat Options Oncol 2:109\u2013118","journal-title":"Curr Treat Options Oncol"},{"key":"1330_CR13","first-page":"175","volume":"11","author":"P Fioretti","year":"1990","unstructured":"Fioretti P, Gadducci A, Del Bravo B, Prato B (1990) The potential of primary cytoreductive surgery in patients with FIGO stages III and IV ovarian carcinoma. Eur J Gynaecol Oncol 11:175\u2013179","journal-title":"Eur J Gynaecol Oncol"},{"key":"1330_CR14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0090-8258(03)00249-X","volume":"90","author":"F Mazzeo","year":"2003","unstructured":"Mazzeo F, Berli\u00e8re M, Kerger J, Squifflet J, Duck L, D\u2019Hondt V, Humblet Y, Donnez J, Machiels JP (2003) Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer. Gynecol Oncol 90:163\u2013169","journal-title":"Gynecol Oncol"},{"key":"1330_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.2002.6849","volume":"88","author":"YM Chan","year":"2003","unstructured":"Chan YM, Ng TY, Ngan HY, Wong LC (2003) Quality of life in women treated with neoadjuvant chemotherapy for advanced ovarian cancer: a prospective longitudinal study. Gynecol Oncol 88:9\u201316","journal-title":"Gynecol Oncol"},{"key":"1330_CR16","first-page":"25","volume":"27","author":"T Giannopoulos","year":"2006","unstructured":"Giannopoulos T, Butler-Manuel S, Taylor A, Ngeh N, Thomas H (2006) Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma. Eur J Gynaecol Oncol 27:25\u201328","journal-title":"Eur J Gynaecol Oncol"},{"key":"1330_CR17","first-page":"61","volume":"73","author":"FG Lawton","year":"1989","unstructured":"Lawton FG, Redman CW, Luesley DM, Chan KK, Blackledge G (1989) Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer. Obstet Gynecol 73:61\u201365","journal-title":"Obstet Gynecol"},{"key":"1330_CR18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0090-8258(91)90335-3","volume":"42","author":"JH Jacob","year":"1991","unstructured":"Jacob JH, Gershenson DM, Morris M, Copeland LJ, Burke TW, Wharton JT (1991) Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer. Gynecol Oncol 42:146\u2013150","journal-title":"Gynecol Oncol"},{"key":"1330_CR19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ygyno.2006.11.025","volume":"105","author":"JY Hou","year":"2007","unstructured":"Hou JY, Kelly MG, Yu H, McAlpine JN, Azodi M, Rutherford TJ, Schwartz PE (2007) Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Gynecol Oncol 105:211\u2013217","journal-title":"Gynecol Oncol"},{"key":"1330_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000084822","volume":"68","author":"D Pectasides","year":"2005","unstructured":"Pectasides D, Farmakis D, Koumarianou A (2005) The role of neoadjuvant chemotherapy in the treatment of advanced ovarian cancer. Oncology 68:64\u201370","journal-title":"Oncology"},{"key":"1330_CR21","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(20011115)92:10<2585::AID-CNCR1611>3.0.CO;2-#","volume":"92","author":"W Kuhn","year":"2001","unstructured":"Kuhn W, Rutke S, Sp\u00e4the K, Schmalfeldt B, Florack G, von Hundelshausen B, Pachyn D, Ulm K, Graeff H (2001) Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer 92:2585\u20132591","journal-title":"Cancer"},{"key":"1330_CR22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1525-1438.1996.06050356.x","volume":"6","author":"E Surwit","year":"1996","unstructured":"Surwit E, Childers J, Atlas I, Nour M, Hatch K, Hallum A, Alberts D (1996) Neoadjuvant chemotherapy for advanced ovarian cancer. Int J Gynecol Cancer 6:356\u2013366","journal-title":"Int J Gynecol Cancer"},{"key":"1330_CR23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1525-1438.2005.15206.x","volume":"15","author":"V Loizzi","year":"2005","unstructured":"Loizzi V, Cormio G, Resta L, Rossi CA, Di Gilio AR, Cuccovillo A, Selvaggi L (2005) Neoadjuvant chemotherapy in advanced ovarian cancer: a case\u2013control study. Int J Gynecol Cancer 15:217\u2013223","journal-title":"Int J Gynecol Cancer"},{"key":"1330_CR24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jamcollsurg.2003.06.004","volume":"197","author":"P Morice","year":"2003","unstructured":"Morice P, Dubernard G, Rey A, Atallah D, Pautier P, Pomel C, Lhomm\u00e9 C, Duvillard P, Castaigne D (2003) Results of interval debulking surgery compared with primary debulking surgery in advanced stage ovarian cancer. J Am Coll Surg. 197:955\u2013963","journal-title":"J Am Coll Surg."},{"key":"1330_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1447-0756.2006.00359.x","volume":"32","author":"SJ Lee","year":"2006","unstructured":"Lee SJ, Kim BG, Lee JW, Park CS, Lee JH, Bae DS (2006) Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery. J Obstet Gynaecol Res 32:99\u2013106","journal-title":"J Obstet Gynaecol Res"},{"key":"1330_CR26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1525-1438.2001.01064.x","volume":"11","author":"F Kayik\u00e7ioglu","year":"2001","unstructured":"Kayik\u00e7ioglu F, K\u00f6se MF, Boran N, Cali\u015fkan E, Tulunay G (2001) Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma. Int J Gynecol Cancer 11:466\u2013470","journal-title":"Int J Gynecol Cancer"},{"key":"1330_CR27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/gyno.1998.5213","volume":"71","author":"I Vergote","year":"1998","unstructured":"Vergote I, De Wever I, Tjalma W, Van Gramberen M, Decloedt J, van Dam P (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71:431\u2013436","journal-title":"Gynecol Oncol"},{"key":"1330_CR28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","volume":"332","author":"ME Burg van der","year":"1995","unstructured":"van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med. 332:629\u2013634","journal-title":"N Engl J Med."},{"key":"1330_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2006.10.055","volume":"105","author":"GD Aletti","year":"2007","unstructured":"Aletti GD, Dowdy SC, Podratz KC, Cliby WA (2007) Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol 105:84\u201389","journal-title":"Gynecol Oncol"},{"key":"1330_CR30","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ajog.2008.06.052","volume":"199","author":"A Fagotti","year":"2008","unstructured":"Fagotti A, Ferrandina G, Fanfani F, Garganese G, Vizzielli G, Carone V, Salerno MG, Scambia G (2008) Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma. Am J Obstet Gynecol. 199:642.e1\u2013646.e1","journal-title":"Am J Obstet Gynecol."},{"key":"1330_CR31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0090-8258(85)90141-6","volume":"20","author":"SS Chen","year":"1985","unstructured":"Chen SS, Bochner R (1985) Assessment of morbidity and mortality in primary cytoreductive surgery for advanced ovarian carcinoma. Gynecol Oncol 20:190\u2013195","journal-title":"Gynecol Oncol"},{"key":"1330_CR32","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ajog.2005.06.074","volume":"193","author":"S Sharma","year":"2005","unstructured":"Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S (2005) Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol 193:2077\u20132082","journal-title":"Am J Obstet Gynecol"},{"key":"1330_CR33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","volume":"94","author":"DS Chi","year":"2004","unstructured":"Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR (2004) Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 94:650\u2013654","journal-title":"Gynecol Oncol"},{"issue":"Suppl 2","key":"1330_CR34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ijgc-00009577-200509001-00099","volume":"15","author":"ME Burg van der","year":"2005","unstructured":"van der Burg ME, Coens C, van Lent M, Kobierska A, Colombo N, Favalli G (2005) The survival benefit of interval debulking surgery (IDS) in advanced ovarian cancer maintained during ten years; the EORTC GCG 55865 study. Int J Gynecol Cancer 15(Suppl 2):79","journal-title":"Int J Gynecol Cancer"},{"key":"1330_CR35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1994.tb13080.x","volume":"101","author":"CW Redman","year":"1994","unstructured":"Redman CW, Warwick J, Luesley DM, Varma R, Lawton FG, Blackledge GR (1994) Intervention debulking surgery in advanced epithelial ovarian cancer. Br J Obstet Gynaecol 101:142\u2013146","journal-title":"Br J Obstet Gynaecol"},{"key":"1330_CR36","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","volume":"351","author":"PG Rose","year":"2004","unstructured":"Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC, Moore DH, Small JM (2004) Gynecologic Oncology Group. Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 351:2489\u20132497","journal-title":"N Engl J Med"},{"key":"1330_CR37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000074644","volume":"65","author":"F Fanfani","year":"2003","unstructured":"Fanfani F, Ferrandina G, Corrado G, Fagotti A, Zakut HV, Mancuso S, Scambia G (2003) Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients. Oncology 65:316\u2013322","journal-title":"Oncology"},{"key":"1330_CR38","first-page":"393","volume":"17","author":"A Onnis","year":"1996","unstructured":"Onnis A, Marchetti M, Padovan P, Castellan L (1996) Neoadjuvant chemotherapy in advanced ovarian cancer. Eur J Gynaecol Oncol 17:393\u2013396","journal-title":"Eur J Gynaecol Oncol"},{"key":"1330_CR39","unstructured":"Vergote CG, Trop\u00e9 F, Amant GB, Kristensen JE, Sardi T, Ehlen N, Johnson RHM, Verheijen MEL, van der Burg AJ, Lacave P, Benedetti Panici GG, Kenter A, Casado C, Mendiola C, Coens G, Stuart S, Pecorelli NS (2008) EORTC-GCG\/NCIC-CTG randomized trial comparing primary debulking surgery with neoadjuvant chemotherapy in stage IIIC-IV ovarian, fallopian tube and peritoneal cancer. Plenary presentation at the 12th Biennial meeting International Gynecologic Cancer Society IGCS, Bangkok, Thailand October 25\u201328, 2008 (abs.)"},{"key":"1330_CR40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11912-003-0008-8","volume":"5","author":"ME Burg van der","year":"2003","unstructured":"van der Burg ME, Vergote I (2003) Gynecological Cancer Group of the EORTC. The role of interval debulking surgery in ovarian cancer. Curr Oncol Rep 5:473\u2013481","journal-title":"Curr Oncol Rep"},{"key":"1330_CR41","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0277-5379(89)90208-3","volume":"25","author":"EE Voest","year":"1989","unstructured":"Voest EE, van Houwelingen JC, Neijt JP (1989) A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log relative risk) as main objectives. Eur J Cancer Clin Oncol 25:711\u2013720","journal-title":"Eur J Cancer Clin Oncol"},{"key":"1330_CR42","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1525-1438.2007.00905.x","volume":"17","author":"A Rafii","year":"2007","unstructured":"Rafii A, Deval B, Geay JF, Chopin N, Paoletti X, Paraiso D, Pujade-Lauraine E (2007) Treatment of FIGO stage IV ovarian carcinoma: results of primary surgery or interval surgery after neoadjuvant chemotherapy: a retrospective study. Int J Gynecol Cancer. 17:777\u2013783","journal-title":"Int J Gynecol Cancer."},{"key":"1330_CR43","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","volume":"72","author":"RE Bristow","year":"1999","unstructured":"Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY (1999) Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 72:278\u2013287","journal-title":"Gynecol Oncol"},{"key":"1330_CR44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1996.4396","volume":"64","author":"PC Liu","year":"1997","unstructured":"Liu PC, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC (1997) Effect of surgical debulking on survival in stage IV ovarian cancer. Gynecol Oncol 64:4\u20138","journal-title":"Gynecol Oncol"},{"key":"1330_CR45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000178760","volume":"76","author":"S Pignata","year":"2009","unstructured":"Pignata S, Scambia G, Savarese A, Breda E, Sorio R, Pisano C, Lorusso D, Cognetti F, Vernaglia Lombardi A, Gebbia V, Scollo P, Morabito A, Signoriello G, Perrone F (2009) Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. Oncology 76:49\u201354","journal-title":"Oncology"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-009-1330-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1330-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T21:49:19Z","timestamp":1739656159000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-009-1330-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,25]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1007\/s00404-009-1330-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,25]]}}}